LAVAL, Quebec, May 19, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the election of eleven directors nominated at its 2015 annual meeting of shareholders today. The detailed results of the vote for the election of directors are set out below:
Name For Withheld Broker Non-Votes ---- --- -------- ---------------- Ronald H. Farmer 259,517,209 2,064,596 12,938,661 Colleen A. Goggins 260,564,263 1,017,542 12,938,661 Robert A. Ingram 258,725,145 2,856,660 12,938,661 Anders Lönner 259,632,031 1,949,774 12,938,661 Theo Melas- Kyriazi 260,811,015 770,790 12,938,661 J. Michael Pearson 255,809,687 5,772,118 12,938,661 Robert N. Power 258,849,981 2,731,824 12,938,661 Norma A. Provencio 260,777,276 804,529 12,938,661 Howard B. Schiller 250,437,448 11,144,357 12,938,661 Katharine B. Stevenson 260,656,695 925,110 12,938,661 Jeffrey W. Ubben 260,166,082 1,415,723 12,938,661
At the annual meeting, shareholders also approved the non-binding advisory vote on named executive officer compensation as disclosed in the proxy statement and appointed PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm until the close of the Company's 2016 annual meeting of shareholders.
The final vote tabulation on all matters voted on at today's meeting will be reported to the U.S. Securities and Exchange Commission on a current report on Form 8-K and such report will be made available on the Company's web site, www.valeant.com.
About Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com
http://photos.prnewswire.com/prnvar/20101025/LA87217LOGO
Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-announces-2015-annual-meeting-results-300085929.html
SOURCE Valeant Pharmaceuticals International, Inc.